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Abstract
Sexually transmitted infections (STIs) continue to be a major public health concern in the
United Kingdom (UK). Epidemiological models have shown that narrowing the time
between STI diagnosis and treatment may reduce the population burden of infection, and
rapid, accurate point-of-care tests (POCTs) have potential for increasing correct treatment
and mitigating the spread of antimicrobial resistance (AMR). We developed the Precise
social science programme to incorporate clinician and patient opinions on potential designs
and implementation of new POCTs for multiple STIs and AMR detection. We conducted
qualitative research, consisting of informal interviews with clinicians and semi-structured
in-depth interviews with patients, in six sexual health clinics in the UK. Interviews with
clinicians focused on how the new POCTs would likely be implemented into clinical care;
these new clinical pathways were then posed to patients in in-depth interviews. Patient
interviews showed acceptability of POCTs, however, willingness to wait in clinic for test
results depended on the context of patients’ sexual healthcare seeking. Patients reporting
frequent healthcare visits often based their expectations and opinions of services and
POCTs on previous visits. Patients’ suggestions for implementation of POCTs included
provision of information on service changes and targeting tests to patients concerned they
are infected. Our data suggests that patients may accept new POCT pathways if they are
given information on these changes prior to attending services and to consider implement-
ing POCTs among patients who are anxious about their infection status and/or who are
experiencing symptoms.
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Introduction
Sexually transmitted infections (STIs) continue to be a major public health concern in the UK,
with approximately 420,000 diagnoses made in England alone in 2017 [1]. Young people con-
tinue to bear the burden of STIs in the UK; diagnoses among 15–24 year-olds are twice as high
in men and seven times as high in women compared to other age groups [1]. Diagnoses of
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections continue to be the
most common STI diagnoses among men-who-have-sex-with-men (MSM) [1]. Other curable
STIs, such as Mycoplasma genitalium (MG), have not traditionally been routinely tested for in
National Health Service (NHS) sexual health clinics (SHCs) as there is limited provision of
accurate, molecular based testing for MG, despite evidence of this infection causing onward
health consequences such as endometritis, cervicitis, pre-term birth and pelvic inflammatory
disease in women [2,3].
The Precise study is a collaboration between clinicians, epidemiologists, microbiologists,
social scientists and industry experts to develop and evaluate rapid nucleic acid amplification
tests (NAATs) -based Point of Care tests (POCTs) for multiple STIs and AMR detection. A
social science programme, including qualitative research and patient and public involvement,
was developed within the Precise study to incorporate patient and clinician opinions on the
potential designs and implementation of new rapid NAAT-based POCTs for CT, NG, MG and
Trichomonas vaginalis (TV) diagnosis and AMR detection in MG and NG infections.
Laboratory-based NAATs are the current gold standard for CT and NG testing [4–6]. Labo-
ratory NAATs usually allow clinical staff to provide patients with results in about a week [7];
some non-laboratory-based NAATs in development promise sensitivity and specificity compa-
rable to laboratory NAATs and provision of results in 30 minutes or less [8], allowing for accu-
rate diagnosis and treatment at the point of care. Epidemiological models have shown that
narrowing the time between diagnosis of infection and treatment may reduce the burden of
infection in the population [9], and rapid, accurate NAAT-based POCTs have the added
potential for increasing likelihood of correct treatment and mitigating the spread of antimicro-
bial resistance (AMR) in STIs [10]. NG and MG infections in particular have shown high
potential for resistance, and reducing the spread of resistant infections is a priority globally
and in the UK [10–13].
Implementation of rapid POCTs within SHCs is likely to necessitate changes to clinical
pathways [14], such as patients providing samples for POCTs prior to a clinical consultation
[15], and in so doing, change patients’ experiences and potentially their perspectives of SHC
attendance. While we have some understanding of clinician and Industry perspectives for pri-
orities for the development of POCTs for STIs [16–19], there is less knowledge of patient per-
spectives on how implementation of these technologies may change patient care [20], and no
published research on patient perspectives for implementing AMR POCTs in SHCs. Here we
report on our qualitative study conducted with patients in SHCs across the UK, as part of the
Precise social science programme.
Methods
We planned qualitative research consisting of informal interviews with clinicians and semi-
structured in-depth interviews with patients in six SHCs in the UK. Two data collection stages
were planned with a year of analysis between them; we hypothesised that this would allow for
iterative adaption of our topic guides to include new areas of enquiry following our mid-term
analysis.
UK SHCs were selected for inclusion in the study based on geographic location, access to a
wide range of patients, and willingness to participate. Geographic locations were chosen to
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represent different areas of the UK, in order to better understand if location was associated
with differing provision or expectations of care. Different types of services were also chosen,
including clinics that have been associated with innovative care and/or testing models along-
side clinics with more traditional models of service delivery.
Prior to patient interviews, consultant-level sexual health clinicians at each of the six clinics
were interviewed to assess: their views of the need for STI and AMR detection NAAT-based
POCTs for their patient population, the ideal design(s), and how they might implement the
tests. Consultant clinicians were chosen as ideal to interview as they are the most senior doc-
tors in the service and, as such, are involved in making key decisions on how their clinical ser-
vices are implemented. Clinician interviews included collaborative development of flowcharts
of potential clinical pathways that would enable test implementation at each service. Verbal
descriptions of these pathway changes were incorporated into our interview topic guides to
allow for realistic portrayal of clinical pathway changes patients could then address in their
interviews. Interview topic guides are included as Supporting information (S1, S2 and S3
Files).
In the patients interviews, participants were told by the interviewer that the design of the
tests, specifically which infections were bundled onto each test cartridge, and if the NAAT-
POCT included AMR as well as infection detection, would influence how much time they
might spend in clinic to wait for results, and if needed, treatment. It was explained that ‘reflex
testing’, or testing for alternate causes of infections in those patient that were found to be nega-
tive in their first test would result in waiting for an additional 30 minutes or longer at clinic
(e.g. those negative for CT/NG might then receive a test for TV and/or MG). Reflex testing
might also be necessary if AMR was not included within an infection detection test, which
would mean that patients found positive for NG or MG infection would need to wait an extra
30 minutes for the result of an AMR POCT test to guide their treatment.
In UK sexual health clinics, patients’ reported sexual behaviours, including the gender(s) of
their recent sexual partners, are used as a proxy for determining the complexity of their clinical
needs. Thus sexual behaviour data are used to triage patients into care pathways, which include
the type of healthcare professional they will see (e.g. nurse or doctor) and the potential types of
tests they will receive. Based on this, we chose to sample patients in each clinic based on their
age and the gender(s) of their reported recent sexual partners, rather than sexual identity. Our
reporting throughout reflects this choice.
All participants invited into the Precise social science study were patients of participating
NHS SHCs who reported symptoms of bacterial STI infection and so were at high risk for
infection. This gave us a greater chance of interviewing patients that had an STI; many partici-
pants received their STI test results before the time of their interview. This allowed us to con-
duct in-depth semi-structured interviews with men and women with a confirmed recent STI
(s) as well as those who have tested negative; knowing patients’ infection status allowed for
exploration of specific circumstances of how their care might have been altered if they had
access to the POCTs under development.
Although research has shown that there are important ethnic differences in knowledge and
experience with sexual health care [21], it was not possible for us to achieve ethnic diversity in
the sample that would allow analysis of those differences. The majority of the population in the
UK is White (59.8% in London; 88.8% in Yorkshire; 95.4% in South West England and 96% in
Scotland) [22,23]; our sample is reflective of this.
Table 1 presents our purposive sample frame. We expected N�54 patients across the six
sites (n�9 per clinic).
Patients were initially screened by a healthcare professional for eligibility and then
approached by a clinic-based researcher at the time of their clinic attendance with an invitation
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to participate in an interview. Healthcare professionals conducting recruitment for the study
described the study to patients as University research for the benefit of improving UK NHS
service provision in SHCs. Potentially eligible patients were invited to provide their first name,
ethnicity, contact details (telephone and/or email address), and their preference for time/day
of contact by the research team. These patients were given a patient information sheet and at
least 24 hours to consider their participation before being contacted by the interviewer to
arrange an interview appointment in the SHC where they had been recruited, or over the
phone. Patient interviews were scheduled at a time of the patients’ preference, including out of
regular working hours and on weekends. At the time of the interview appointment and prior
to the interview, patients gave their full informed consent to participate. Participants each
received a £20 voucher for their participation.
SF, a man in his early 40s with over 15 years’ experience in qualitative research, conducted
the first set of interviews, and AP, a woman in her early 30s, with over 5 years’ experience in
qualitative research, conducted the second set of interviews. Both SF and AP presented them-
selves to healthcare professionals and potential participants in participating clinics as Univer-
sity researchers that were independent from the company producing the NAAT-based POCTs
discussed in the interviews. Both interviewers encouraged positive, negative and indifferent
views of the tests to be expressed.
Interviews were audio recorded and transcribed verbatim. Transcripts were then checked
for accuracy (cleaned) against the audio recording by the interviewers (SF, AP). A content
analysis approach was used to capture and uncover substantive meanings within the dataset.
Data were analysed using a thematic approach. SF and AP looked for common themes across
the dataset. Transcripts were coded thematically in NVivo 11. Framework was used as a tool to
organise themes, as this approach allows for reading themes across and within cases, giving
opportunity for both in-depth case study analysis and explanatory analyses based on compari-
son of themes across the dataset [24]. SF led the analysis and selected initial themes, AP then
reviewed the entire dataset and generated and assigned themes independently to transcripts to
improve reliability. Finally, all themes were agreed on by both SF and AP prior to finalising the
analysis and drafting the manuscript.
We report the research in accordance with the consolidated criteria for reporting qualitative
research (COREQ) checklist (Supporting information: S4 File).
Ethics
Ethical approval was given in June 2015 by London Bridge Research Ethics Committee, refer-
ence 15/LO/0535: Developing patient-centred, rapid, Point-of-Care testing including antimicro-
bial resistance markers for specialist sexual health services in the NHS: the Precise study social
science programme.
Results
Six clinics across UK participated: London (n = 3), Devon, Yorkshire, and Eastern Scotland.
London SHCs included two central London locations, including one associated with
Table 1. Purposive sample frame, per clinic.
Men reporting exclusively heterosexual behavior Men reporting sex with men Women reporting sex with men Total
Ages 16–24 1 1 1 3
Ages 25–35 1 1 1 3
Ages 35–44 1 1 1 3
Total 3 3 3 9
https://doi.org/10.1371/journal.pone.0215380.t001
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implementation of novel testing pathways and modern designs to encourage patient atten-
dance. A total of 148 patients agreed to be contacted by the research team for an interview, of
which 63 patients (42.6%) completed an interview. Identification of potentially eligible patients
was conducted in different ways by members of the healthcare team in each of the six clinics
(e.g., some patients were invited before eligibility screening and then asked eligibility ques-
tions, whereas others did the opposite), and so we cannot provide meaningful data on patients
who declined to provide contact information to the study team.
Data were collected in two stages: June 2015 –February 2016 and February 2017-August
2017. Two interviews were unusable due to recording errors. Of 61 useable patient interviews,
18 women reporting sex with men, 17 men who reported exclusively heterosexual behaviour
and 26 men reporting sex with men, participated.
The mean age for heterosexual male participants was 25 (range 17–37), for men reporting
sex with men was 30 (range 19–40), and for female participants was 28 years (range 20–41).
No patients aged 16 years or between 42–45 years of age participated. The majority of partici-
pants (50/61) were White, almost one-third (27.9%; 17/61) of participants were students (n = 9
London, n = 4 Yorkshire, n = 2 Devon, n = 2 Scotland), and four were unemployed and not in
education. Full demographics details for all participants are shown in Table 2.
During interviews, we asked participants to describe their most recent clinic visit.
Following participants’ description of their recent clinic experience, we discussed the
NAAT-based POCTs. We initially gave very little information about the tests, asking their
opinions of the potential to receive their test results within their same visit to clinic gener-
ally, and then explored participants’ willingness to wait for NAAT-based POCT results in a
scenario where the new pathway would extend their time spent waiting in the clinic. We
Table 2. Demographics details for all participants�.
Gender Female (%) Male (%) Total Column %
18 (29.5%) 43 (70.5%) 61 100%
Age
16–24 6 (31.6%) 13 (68.4%) 19 31.1%
25–34 9 (31%) 20 (68.9%) 29 47.5%
35–44 3 (23%) 10 (76.9%) 13 21.3%
Ethnicity 61 100%
Asian or Asian British 3 (75%) 1 (25%) 4 6.5%
Black/Black British 1 (33.3%) 2 (66.6%) 3 4.9%
Mixed race 0 (0%) 2 (100%) 2 3.3%
Other (not specified) 1 (100%) 0 (0%) 1 1.6%
White/White British 13 (26%) 37 (74%) 50 82%
Prefer not to answer 0 (0%) 1 (100%) 1 1.6%
Sexual behaviour 61 100%
Men reporting sex with men - 26 (100%) 26 42.6%
Men reporting exclusively heterosexual behaviour - 17 (100%) 17 27.9%
Women reporting sex with men 18 (100%) - 18 29.5%
Occupation 61 100%
Employed 10 (25%) 30 (75%) 40 65.6%
Student 6 (35.3%) 11 (64.7%) 17 27.9%
Unemployed 2 (50%) 2 (50%) 4 6.5%
� All data are self-reported
https://doi.org/10.1371/journal.pone.0215380.t002
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next discussed participants’ opinions on the potential new NAAT-based POCT pathways.
We report these data here in the order they appeared in the interview. The following main
themes emerged, and are explained in detail using quotes from the respondents, below: ini-
tial impressions, willingness to wait for POCT results, reflex testing and recommendations
for implementation. These descriptive data led to our explanatory analysis, exploring how
patients’ levels of experience influenced their opinions and expectations for their sexual
healthcare. Finally, we report participants’ recommendations for implementation of the
tests.
The full list of themes is shown in Fig 1. Asterisked nodes represent themes that emerged
independently of the questions asked by the interviewer. Non-asterisked codes represent
themes that follow directly from the topic guides (Supporting information: S2 and S3 Files).
Initial impressions
Most participants were enthusiastic about the potential to receive diagnosis and treatment
within one clinic visit; many initially assumed that the POCTs would mean that their time in
clinic would be less than current practice.
“Well I’d be happy with that, because I mean you’d be in and out quickly, and everyone wants
to know that day. I—I wanted to know that day.”
-Man reporting exclusively heterosexual behaviour age 18, London (LA02)
“I think it’s very good, yeah, both for patients and doctors and nurses. I think it’s quicker, eas-
ier, to get results back—yeah, no, a very good idea.”
– Man reporting exclusively heterosexual behaviour age 32, Yorkshire (B08)
Turn-around-time and willingness to wait for results. Following discussion of initial
impressions of the tests, participants were given a brief explanation on the NAAT-based
POCTs: the test will diagnose CT, NG, TV, and MG infections and the turn-around-time from
sample into the cartridge to a diagnostic result will be�30 minutes. Participants were then
told that their time in clinic was likely to be longer than currently, to accommodate the test
turn-around-time and results delivery. Most participants described this scenario as being pref-
erable to current practice.
“So I’d rather just sit an hour and a half one day and not have to waste the time travelling
[back] to the clinic . . . if I can just travel one time and be seen in one to two hours rather than
over two days [that] is, I think, better.”
-Woman reporting sex with men age 22, London (LA01)
“I think for any test you feel apprehensive and you feel uncomfortable. So any shortening of
that time from test to solution is a positive thing in my eyes.”
– Man reporting exclusively heterosexual behaviour age 22, Yorkshire (B01)
We then went on to describe the scenario of reflex testing, where patients might be asked to
undergo a second test following the results of the first NAAT-based POCT. Participants were
mixed in their response to wait an additional 30 minutes for reflex testing, with many ques-
tioning why all infections and AMR were not able to be included on a single cartridge. Several
A qualitative study of UK patient opinions and expectations for POCTs for STIs and AMR
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participants discussed that reflex testing would be considered acceptable in specific circum-
stances, but not in others.
When analysing the data for factors that explain differences in participants’ opinions of
willingness to wait for the results of the proposed NAAT-based POCTs, a strong theme
emerged about the context of sexual healthcare seeking. One young man explained that, for
Fig 1. NVivo nodes. � Respondent driven themes.
https://doi.org/10.1371/journal.pone.0215380.g001
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him, waiting in clinic for a 30-minute test, or a series of 30-minute tests (e.g. in the case of
reflex testing) would be time spent doing something “important” and was thus preferable to
“sitting and waiting” for laboratory results at home:
“[The POCTs are] much better than sitting and waiting around, because no one enjoys that.
And, it’s not a ‘time spent’ issue, it’s a ‘what have you spent your time doing’ issue, and if a lot
of that time is filled up with something that you or I feel is important, then that’s fine with me.
- Man reporting exclusively heterosexual behaviour age 22, Yorkshire (B01)
When investigating what “something you or I feel is important” may mean, we found that
many participants explicitly described situations where they would be willing to wait if they
perceived themselves at risk for infection. Participants described feelings of being at risk for
infection if they had genital symptoms or engaged in sexual risk-taking (e.g. condomless sex),
such as this young man:
“I mean, if I was in a position where I’d had unprotected sex with people and felt like I was at
the risk of STIs, then, yes, I’d be more than happy to wait . . . I think it all comes from gauging
how much at risk I am at the time as to how much amount of time that I’m willing to put into
getting tested and getting it sorted.”
-Man reporting sex with men age 20, Devon (P09)
Although the NAAT-POCT pathways we described were an acceptable change from cur-
rent practice for most participants, some felt that spending additional time waiting for results
at the clinic would not be acceptable, such as this young woman recruited at one of the London
clinics:
“Probably [I would prefer] less time [in clinic] and a text message in a few days. . . . Yeah.
Well if I’m honest, I’ve not really had much of a problem with the waiting time of getting the
results [by text message]. . .”
- Woman reporting sex with men age 20, London (LA03)
Most participants that preferred the current testing and results system at the clinic to the
proposed new NAAT-based POCT pathways expressed that waiting at clinic for 30 minutes or
more from sampling to results was too time consuming. Some, such as the young woman
quoted above, felt that waiting for about a week for a text message with her results was accept-
able; she did not see the need to change the current care pathway. Another participant felt that
the turn-around-time was unacceptable compared with the instant HIV test he had taken sev-
eral years earlier:
“No, that’s long, my friend. That’s very, very, very long. Yes. If it is possible to get it within an
average of 15 minutes, now we’re fine.”
- Man reporting exclusively heterosexual behaviour age 33, Yorkshire (B02).
Some clinicians in participating SHCs directed which infections patients tested for, based
on their self-reported sexual history, while others took a more patient-led approach, allowing
patients to request a “full screen” of potential STIs and HIV. Regardless of the type of clinic
attended, most participants felt that testing for some infections with the POCTs was either
A qualitative study of UK patient opinions and expectations for POCTs for STIs and AMR
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preferable or an acceptable compromise to waiting for all their STI testing results to return
from the laboratory in about a week:
“I mean, it’s a shame it couldn’t all be done at the same time so you wouldn’t have to wait,
but if that was the way that it’s done, then I would rather have some results back straight
away and just have to wait for the other ones. . .”
–Men reporting sex with men age 27, London (LA09)
However, there were some that felt it was not acceptable to receive their diagnoses at differ-
ent times. These patients felt that the process was “half a job” and “incomplete” until they
received all their results and so would prefer the current system:
“. . . I’d just think what’s the point in getting some of it in half an hour when you can’t have it
all in half an hour . . . I don’t like doing things half—half a job.”
- Woman reporting sex with men age 21, Yorkshire (B07).
“It’s—that’s sort of an incomplete process, you’d want to know the full score, as you’re there. I
think it’s just like as I said initially, you don’t want to wait for so long to hear about some
other things that were sort of still pending. You’d want to know everything straight away, and
that’s why—because that’s why you went to the clinic.”
– Man reporting exclusively heterosexual behaviour age 30, London (LA11)
‘Experienced’ and ‘less-experienced’ patient views. Among our participants, we identi-
fied a subgroup of ‘experienced patients’. Although all of the participants in this study were
patients of sexual health services, we defined ‘experienced patients’ as a discrete group of par-
ticipants who described one or more of the following: screening for infections often, living
with a chronic condition, acquiring a high level of familiarity with NHS settings through
accessing family planning, child health services, or similar, and/or having a medical back-
ground or working in the NHS. The majority of our participants were classed as ‘experienced’;
21.3% (13/61) of participants had little or no prior experience with sexual health clinics and/or
health systems more generally and so were described as ‘less experienced patients’ (see Table 3
for demographic details of ‘experienced’ and ‘less experienced patients’). Men reporting exclu-
sively heterosexual behaviour were the largest group among the ‘less experienced patients’
(61.5%).
‘Experienced patients’ often built expectations of sexual health services and opinions of the
POCTs based on experiences with previous medical visits; one female participant described
her expectations based on experiences with medical appointments for herself and her children:
“I would have been happy to wait another half an hour [after the initial test]. Because when I
kind of think about other things that I’ve had done, like screening for breast lumps, you accept
that, I would accept that there, I’d been there for two hours before, waiting for the whole, the
biopsy, the mammogram, the ultrasound and the various talking to the consultants before
and afterwards. . . . Equally, my children, I’d taken them to the paediatrics’ centre and I’ve
waited for two hours for them, but I’d gone away with a clearer picture of what’s going on. So
I’d be happy with that. . .”
-Woman reporting sex with men age 41, Devon (P07)
A qualitative study of UK patient opinions and expectations for POCTs for STIs and AMR
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‘Experienced patients’ were also more likely to be sceptical that a 30-minute turn-around-
time would mean that their results would be delivered within that timeframe:
“But then would that half-an-hour be half-an-hour if there’s if there’s a load of people wait-
ing? . . .will everyone get half-an-hour treatment?”
-Woman reporting sex with men age 31, (LA06)
Based on their previous experiences of using SHCs, these participants envisioned issues
that may potentially arise once the NAAT-based POCT was in clinical use:
“It seems good I guess. My first reaction was, well, if the clinic has one [machine], and you see
people every five minutes, you’re going to end up with a massive queue just to wait half-an-
hour for each test.”
-Woman reporting sex with men age 28, (B09)
Within this sub-group, acceptance of the NAAT-based POCTs and their opinions of receiv-
ing diagnoses at different times often were based on their knowledge of sexual health:
“I think for me personally, I’d be okay because I know the people that I have sex with, like our
group statistically, chlamydia and gonorrhoea are the most common.”
-Woman reporting sex with men age 21, (LC12)
Recommendations for implementation
When looking at recommendations for implementation of POCTs, there was significant diver-
sity among our participants with regard to the knowledge and/or experience of pathways and
Table 3. Demographic details: ‘Experienced’ and ‘less experienced’ patients.
Experienced patients (%) Less experienced patients (%) Total
All participants 48 (%) 13 (%) 61
Age�
16–24 14 (77.8%) 4 (22.2%) 18
25–34 21 (72.4%) 8 (27.6%) 29
35–44 12 (92.3%) 1 (0.7%) 13
Gender�
Female 15 (83.3%) 3 (16.7%) 18
Male 33 (76.7%) 10 (23.3%) 43
Transgender/transsexual 0 (0%) 0 (0%) 0
Sexual behaviour�
Men reporting exclusively heterosexual behaviour 9 (52.9%) 8 (47.1%) 17
Women reporting sex with men 15 (83.3%) 3 (16.7%) 18
Men reporting sex with men 24 (92.3%) 2 (7.7%) 26
Recruitment sites
London 30 (85.7%) 5 (14.3%) 35
Yorkshire 6 (60%) 4 (40%) 10
Devon 7 (87.5%) 1 (12.5%) 8
Scotland 5 (62.5%) 3 (37.5%) 8
� Self-reported data
https://doi.org/10.1371/journal.pone.0215380.t003
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processes present in SHCs. Our data show that experience and knowledge of SHCs plays a role
in how patients form their opinions and expectations of these services. These opinions and
expectations led to participant recommendations for the implementation of POCTs. Partici-
pants frequently expressed their desire for information about steps involved in point of care
testing, estimations of duration of clinic visits being available prior to attending and the ratio-
nale behind AMR testing.
“I think if I knew from the start how long I was going to be there, I’d be like, ‘okay that’s fine.’
. . . But if I’d have got to what I thought was going to be the end of my appointment . . . and
then they were like, ‘you’ll have to wait half an hour.’ I’d say, ‘why couldn’t you have told me
this before I was like thinking I was going to leave in five minutes from now, and I’m sat here
for an extra 30 minutes?’”
- Woman reporting sex with men age 28, Yorkshire (B09)
“. . . I think as long as you understand the process and why this is happening, then, yes, I
would have no issue with that whatsoever. . . . You know, it’s your health so it’s putting that
time aside to make sure that you get the right results and the right treatment is really impor-
tant. But yes, understanding the process, I think, is the key part of that.”
- Man reporting sex with men age 35, Devon (P08)
Participants’ suggestions to increase acceptability of new pathways for POCTs also
included targeting tests to those that are concerned they are infected (e.g. those presenting as
symptomatic).
“. . .maybe it’s kind of tailored to people who already have a suspicion of having gonorrhoea
or chlamydia. . . if you go in with suspicions or to find out about gonorrhoea, chlamydia, then
it’d be more helpful.”
–Man reporting sex with men age 26, London (LA08)
Furthermore, a number of patients said they would like to have a choice to either wait for
the results in the clinic, or return later that day for their results:
“I imagine, you’re okay to just go and get a coffee somewhere, either in the hospital or outside,
and come back in 30 minutes? I don’t know if they need you to stay in the building necessarily,
but I think just by giving people options just being sort of kind and creating a nice atmosphere
and be like, like you got 30 minutes until your result, kind of, do what you please. So yes, for
me, I would prefer it if I didn’t have to stay in the waiting room.”
–Man reporting sex with men age 27, London (LB07)
Discussion
Context within the existing literature
This is the first study of patients’ opinions and priorities for POCTs for STI and AMR detec-
tion implementation in UK SHCs. Previous studies have focused on patients’ views of home-
sampling and/or home-testing [25,26]; however, these studies have shown that patients have
different opinions and concerns around these services than they do of SHCs. Several studies
have shown a general acceptability of waiting times for same day results, even if that means
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extending that time from 20 minutes to up to two hours [27–29]. None of these studies have
been conducted in the UK and none have reported the context of patients’ decisions to wait
for their results and so our ability to understand how to implement NAAT-based POCTs for
STIs is limited.
Miners et al. explored preferences for STI testing services and found that their participants
(patients of SHCs) preferred to receive their results on the same day, placed the highest impor-
tance in choice of where to attend for STI testing on receiving specialist knowledge and testing
for all infections at the same time [30]. Several of our participants similarly indicated prefer-
ence for SHCs based on their specialist care, and discussed testing for as many infections as
possible on the same clinic visit. Interestingly, most of our participants were unconcerned
about receiving results for different infections at different times, despite their overall lack of
familiarity with POCTs (including the HIV rapid test). Our data strongly indicate that receiv-
ing results at different times was less than ideal, but still preferable to current practice.
Although it might be expected that patients generally prefer their test results faster than is
currently possible, our data show that patients’ views are highly contextual, with a strong them
among our participants that NAAT-based POCTs and willingness to wait for results is contin-
gent on the reason(s) for their clinic attendance. In the treatment of curable STIs specifically,
NAAT-based POCTs reduce the duration of infection through prompt treatment and expe-
dited partner notification, reduce overtreatment and may mitigate the development of AMR
through targeted prescribing [18]. However, the potential for NAAT-based POCTs to increase
testing coverage has been questioned, given the existing cultural and health barriers to access-
ing sexual health services [18]. Our study shows that it is possible to critically engage with
patients about their opinions of NAAT-based POCTs for STIs, and their priorities and path-
ways for implementation of these new technologies, which may increase acceptability and thus
use of these services in the future.
Debates in medicine around the volume of information that is made available to patients
lack consensus [31]. While patients are believed to almost always wish to receive as much
information as possible [31,32], research has shown that care providers are rarely aware of this
inclination [31,33–36]. Many studies have indicated that patients’ dissatisfaction with the pro-
vision of information from healthcare providers affects the quality and outcomes of care,
including patients’ satisfaction with health services [31,32,37–44]. Patients’ satisfaction is, in
turn, associated with their compliance with treatment directives [35,45–46], which is itself an
important indicator of patient outcomes.
Limitations
We did not reach our purposive sample goal for men reporting exclusively heterosexual behav-
iour between 16–24 and 35–44 years of age, and women reporting sex with men between 35–
44 years of age, therefore these age groups are under-represented in this sample. Men report-
ing sex with men are over-represented in the sample, following our attempts to increase enrol-
ment following underrepresentation in the first sub-study; response by men reporting sex with
men was higher than anticipated in the second sub-study. As a result of our limited data from
men reporting exclusively heterosexual behaviour between 16–24 and 35–44 years of age, and
women reporting sex with men between 35–44 years of age, we may have more limited theo-
retical generalisability than intended. As men reporting exclusively heterosexual behaviour
were the largest group among the ‘less experienced’ patients, it would be advantageous for
the study to have a better insight into their views. We did however achieve theme saturation in
our sample, indicating that new participants would have been unlikely to express different
opinions.
A qualitative study of UK patient opinions and expectations for POCTs for STIs and AMR
PLOS ONE | https://doi.org/10.1371/journal.pone.0215380 April 16, 2019 12 / 16
Our agreement of 42.6% (63/148) of patients that provided contact information and went
on to complete an interview is low as compared with other qualitative interview studies, which
may have biased our sample. We complied with recommendations for best ethical practice for
conducting research in healthcare settings by having healthcare professionals at each partici-
pating clinic identify potentially eligible participants as this allows patients to refuse approach
for anything other than their medical care. However, this means that we are unable to provide
meaningful data on patients who declined to provide contact information to the study team.
Healthcare professionals in each of the six clinics identified patients in different ways; some
asked every patient in the waiting room if they would like to participate (regardless of potential
eligibility) and others asked only potentially eligible patients to participate. However, we can
see that there was a high level of diversity in attrition across clinics in the time period between
acceptance of the contact form and participating in an interview: 31% (5/16) of Yorkshire-
based patients, 54.5% (42/77; 60%, 52%, 45% in each clinic) of all London-based patients, 70%
(20/29) of Devon-based patients and 69.2% (18/26) of Scotland-based patients who provided
contact information did not go on to complete an interview. The majority of patients that did
not complete an interview after our attempts to contact them passively refused (97%, 114/117).
Failure to respond to our calls/emails to schedule an interview or failure to answer their phone
or show up in person for a scheduled interview were considered passive refusal.
Interviewers may influence data collection in human subjects research; we considered this
in our analysis by initially conducting separate analyses for each set of interviews. When we
examined our dataset to explore the potential differences between the two sets of interviews we
could not find any significant differences. Additionally, although the interviewers presented
themselves as neutral towards the technology, it is possible that some participants saw the
interviewers as representatives of the NAAT-based POCTs, which may have caused some to
mitigate their stated opinions of the tests during the interviews.
Conclusions
Our study shows patients’ willingness to wait in clinic was often dependent on their self-
assessed risk for infection. Insight into patients’ priorities for care, and their suggestions that
specific, directed messaging may allow acceptability of various changes related to adoption of
NAAT-based POCTs in SHCs gives concrete guidance for implementation of these tests. In
particular, patients recommended targeting tests to those that are concerned they are infected
and giving patients a choice to either wait for the results in the clinic, or return later that day
for their results. Adhering to these suggestions for NAAT-based POCT implementation may
lead to good acceptability of new clinical pathways for these diagnostics. We recommend fur-
ther research when these tests are made available, to test these theories in practice.
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